.png)
Live Vaccines Market by Type and Application- Global Industry Analysis & Forecast to 2027
Published On : March 2021 Pages : 158 Category: Pharma & Healthcare Report Code : HC0316336
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Live Vaccines Market By Type (Monovalent Live Vaccines, Multivalent Live Vaccines) and Application (Adults, Children)- Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Live Vaccines Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.Live vaccine is bacterium or virus to make its mutation in artificial condition, lose pathogenicity but retain immunogenicity and reproduction ability and remaining virulence, after vaccinating, there is the reproduction or replication of certain level inside human body, resemble a light natural infection process, but won't cause a person to come on.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global Live Vaccines Market size market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- SouthAmerica
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Merck
- GlaxoSmithKline
- Pfizer
- Novartis
- AstellasPharma
- Emergent BioSolutions
- AstraZeneca
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Live Vaccines Market, ByType, Estimates and Forecast, 2017-2027 ($Million)
o Monovalent Live Vaccines
o Multivalent Live Vaccines
· Live Vaccines Market, ByApplication, Estimates and Forecast, 2017-2027 ($Million)
o Adults
o Children
· Live Vaccines Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Merck
o GlaxoSmithKline
o Pfizer
o Novartis
o Astellas Pharma
o Emergent BioSolutions
· Live Vaccines Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Live Vaccines Market, By Country
o U.S. Live Vaccines Market
o Canada Live Vaccines Market
o Mexico Live Vaccines Market
o Europe
§ Europe Live Vaccines Market, By Country
· Germany Live Vaccines Market
o UK Live Vaccines Market
o France Live Vaccines Market
o RussiaLive Vaccines Market
o Italy Live Vaccines Market
o Rest of Europe Live Vaccines Market
o Asia-Pacific
§ Asia-Pacific Live Vaccines Market, By Country
o ChinaLive Vaccines Market
o Japan Live Vaccines Market
o South KoreaLive Vaccines Market
o India Live Vaccines Market
o Southeast AsiaLive Vaccines Market
o Rest of Asia-Pacific Live Vaccines Market
o South America
§ South AmericaLive Vaccines Market
o Brazil Live Vaccines Market
o ArgentinaLive Vaccines Market
o ColumbiaLive Vaccines Market
o Rest of South America Live Vaccines Market
o Middle East and Africa
§ Middle East and AfricaLive Vaccines Market
o Saudi ArabiaLive Vaccines Market
o UAELive Vaccines Market
o EgyptLive Vaccines Market
o NigeriaLive Vaccines Market
o South Africa Live Vaccines Market
o Rest of MEA Live Vaccines Market
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Live Vaccines Market, By Type
5.1. Introduction
5.2. Global Live Vaccines Revenue and Market Share by Type (2017-2021)
5.2.1. Global Live Vaccines Revenue and Revenue Share by Type (2017-2021)
5.3. Monovalent Live Vaccines
5.3.1. Global Monovalent Live Vaccines Revenue and Growth Rate (2017-2021)
5.4. Multivalent Live Vaccines
5.4.1. Global Multivalent Live Vaccines Revenue and Growth Rate (2017-2021)
6. Live Vaccines Market, By Application
6.1. Introduction
6.2. Global Live Vaccines Revenue and Market Share by Application (2017-2021)
6.2.1. Global Live Vaccines Revenue and Revenue Share by Application (2017-2021)
6.3. Adults
6.3.1. Global Adults Revenue and Growth Rate (2017-2021)
6.4. Children
6.4.1. Global Children Revenue and Growth Rate (2017-2021)
7. Live Vaccines Market, By Region
7.1. Introduction
7.2. Global Live Vaccines Revenue and Market Share by Regions
7.2.1. Global Live Vaccines Revenue by Regions (2017-2021)
7.3. North America Live Vaccines by Countries
7.3.1. North America Live Vaccines Revenue and Growth Rate (2017-2021)
7.3.2. North America Live Vaccines Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Live Vaccines by Countries
7.4.1. Europe Live Vaccines Revenue and Growth Rate (2017-2021)
7.4.2. Europe Live Vaccines Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Live Vaccines by Countries
7.5.1. Asia-Pacific Live Vaccines Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Live Vaccines Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Live Vaccines by Countries
7.6.1. South America Live Vaccines Revenue and Growth Rate (2017-2021)
7.6.2. South America Live Vaccines Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Live Vaccines by Countries
7.7.1. Middle East and Africa Live Vaccines Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Live Vaccines Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. Merck
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. GlaxoSmithKline
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Pfizer
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Novartis
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Astellas Pharma
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Emergent BioSolutions
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. AstraZeneca
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
9. Live Vaccines Market Forecast (2022-2027)
9.1. Global Live Vaccines Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Live Vaccines Market Forecast by Regions (2022-2027)
9.2.1. North America Live Vaccines Market Forecast (2022-2027)
9.2.1.1. United States Live Vaccines Market Forecast (2022-2027)
9.2.1.2. Canada Live Vaccines Market Forecast (2022-2027)
9.2.1.3. Mexico Live Vaccines Market Forecast (2022-2027)
9.2.2. Europe Live Vaccines Market Forecast (2022-2027)
9.2.2.1. Germany Live Vaccines Market Forecast (2022-2027)
9.2.2.2. France Live Vaccines Market Forecast (2022-2027)
9.2.2.3. UK Live Vaccines Market Forecast (2022-2027)
9.2.2.4. Russia Live Vaccines Market Forecast (2022-2027)
9.2.2.5. Italy Live Vaccines Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Live Vaccines Market Forecast (2022-2027)
9.2.3. Asia-Pacific Live Vaccines Market Forecast (2022-2027)
9.2.3.1. China Live Vaccines Market Forecast (2022-2027)
9.2.3.2. Japan Live Vaccines Market Forecast (2022-2027)
9.2.3.3. Korea Live Vaccines Market Forecast (2022-2027)
9.2.3.4. India Live Vaccines Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Live Vaccines Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Live Vaccines Market Forecast (2022-2027)
9.2.4. South America Live Vaccines Market Forecast (2022-2027)
9.2.4.1. Brazil Live Vaccines Market Forecast (2022-2027)
9.2.4.2. Argentina Live Vaccines Market Forecast (2022-2027)
9.2.4.3. Columbia Live Vaccines Market Forecast (2022-2027)
9.2.4.4. Rest of South America Live Vaccines Market Forecast (2022-2027)
9.2.5. Middle East and Africa Live Vaccines Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Live Vaccines Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Live Vaccines Market Forecast (2022-2027)
9.2.5.3. Egypt Live Vaccines Market Forecast (2022-2027)
9.2.5.4. Nigeria Live Vaccines Market Forecast (2022-2027)
9.2.5.5. South Africa Live Vaccines Market Forecast (2022-2027)
9.2.5.6. Turkey Live Vaccines Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Live Vaccines Market Forecast (2022-2027)
9.3. Live Vaccines Market Forecast by Type (2022-2027)
9.3.1. Live Vaccines Forecast by Type (2022-2027)
9.3.2. Live Vaccines Market Share Forecast by Type (2022-2027)
9.4. Live Vaccines Market Forecast by Application (2022-2027)
9.4.1. Live Vaccines Forecast by Application (2022-2027)
9.4.2. Live Vaccines Market Share Forecast by Application (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Live Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Live Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Live Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Live Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Live Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Live Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Live Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Live Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Live Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Live Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Live Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Live Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Live Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Live Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Live Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Live Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Live Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Live Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Live Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Live Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Live Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Live Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Live Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Live Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Live Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Live Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Live Vaccines Revenue and Revenue Share by Type (2017-2019)
Figure Global Monovalent Live Vaccines Revenue and Growth Rate (2017-2019)
Figure Global Multivalent Live Vaccines Revenue and Growth Rate (2017-2019)
Table Global Live Vaccines Revenue and Revenue Share by Application (2017-2019)
Figure Global Adults Revenue and Growth Rate (2017-2019)
Figure Global Children Revenue and Growth Rate (2017-2019)
Table Global Live Vaccines Revenue by Regions (2017-2019)
Figure North America Live Vaccines Growth Rate (2017-2019)
Figure North America Live Vaccines Revenue and Growth Rate (2017-2019)
Figure North America Live Vaccines by Countries (2017-2019)
Figure North America Live Vaccines Revenue (Million USD) by Countries (2017-2019)
Figure United States Live Vaccines Growth Rate (2017-2019)
Figure United States Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Live Vaccines Growth Rate (2017-2019)
Figure Canada Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Live Vaccines Growth Rate (2017-2019)
Figure Mexico Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Live Vaccines Growth Rate (2017-2019)
Figure Europe Live Vaccines Revenue and Growth Rate (2017-2019)
Figure Europe Live Vaccines by Countries (2017-2019)
Figure Europe Live Vaccines Revenue (Million USD) by Countries (2017-2019)
Figure Germany Live Vaccines Growth Rate (2017-2019)
Figure Germany Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Live Vaccines Growth Rate (2017-2019)
Figure France Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Live Vaccines Growth Rate (2017-2019)
Figure UK Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Live Vaccines Growth Rate (2017-2019)
Figure Russia Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Live Vaccines Growth Rate (2017-2019)
Figure Italy Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Live Vaccines Growth Rate (2017-2019)
Figure Rest of Europe Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Live Vaccines Growth Rate (2017-2019)
Figure Asia-Pacific Live Vaccines Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Live Vaccines by Countries (2017-2019)
Figure Asia-Pacific Live Vaccines Revenue (Million USD) by Countries (2017-2019)
Figure China Live Vaccines Growth Rate (2017-2019)
Figure China Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Live Vaccines Growth Rate (2017-2019)
Figure Japan Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Live Vaccines Growth Rate (2017-2019)
Figure Korea Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Live Vaccines Growth Rate (2017-2019)
Figure India Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Live Vaccines Growth Rate (2017-2019)
Figure Southeast Asia Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Live Vaccines Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Live Vaccines Growth Rate (2017-2019)
Figure South America Live Vaccines Revenue and Growth Rate (2017-2019)
Figure South America Live Vaccines by Countries (2017-2019)
Figure South America Live Vaccines Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Live Vaccines Growth Rate (2017-2019)
Figure Brazil Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Live Vaccines Growth Rate (2017-2019)
Figure Argentina Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Live Vaccines Growth Rate (2017-2019)
Figure Columbia Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Live Vaccines Growth Rate (2017-2019)
Figure Rest of South America Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Live Vaccines Growth Rate (2017-2019)
Figure Middle East and Africa Live Vaccines Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Live Vaccines by Countries (2017-2019)
Figure Middle East and Africa Live Vaccines Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Live Vaccines Growth Rate (2017-2019)
Figure Saudi Arabia Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Live Vaccines Growth Rate (2017-2019)
Figure United Arab Emirates Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Live Vaccines Growth Rate (2017-2019)
Figure Egypt Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Live Vaccines Growth Rate (2017-2019)
Figure Nigeria Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Live Vaccines Growth Rate (2017-2019)
Figure South Africa Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Live Vaccines Growth Rate (2017-2019)
Figure Turkey Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Live Vaccines Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Live Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Table Merck Live Vaccines Financial Overview
Table GlaxoSmithKline Live Vaccines Financial Overview
Table Pfizer Live Vaccines Financial Overview
Table Novartis Live Vaccines Financial Overview
Table Astellas Pharma Live Vaccines Financial Overview
Table Emergent BioSolutions Live Vaccines Financial Overview
Table AstraZeneca Live Vaccines Financial Overview
Figure Global Live Vaccines Revenue (Millions USD) and Growth Rate (2019-2027)
Table Live Vaccines Market Forecast by Regions (2019-2027)
Figure North America Live Vaccines Market Forecast (2019-2027)
Figure United States Live Vaccines Market Forecast (2019-2027)
Figure Canada Live Vaccines Market Forecast (2019-2027)
Figure Mexico Live Vaccines Market Forecast (2019-2027)
Figure Europe Live Vaccines Market Forecast (2019-2027)
Figure Germany Live Vaccines Market Forecast (2019-2027)
Figure France Live Vaccines Market Forecast (2019-2027)
Figure UK Live Vaccines Market Forecast (2019-2027)
Figure Russia Live Vaccines Market Forecast (2019-2027)
Figure Italy Live Vaccines Market Forecast (2019-2027)
Figure Rest of Europe Live Vaccines Market Forecast (2019-2027)
Figure Asia-Pacific Live Vaccines Market Forecast (2019-2027)
Figure China Live Vaccines Market Forecast (2019-2027)
Figure Japan Live Vaccines Market Forecast (2019-2027)
Figure Korea Live Vaccines Market Forecast (2019-2027)
Figure India Live Vaccines Market Forecast (2019-2027)
Figure Southeast Asia Live Vaccines Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Live Vaccines Market Forecast (2019-2027)
Figure South America Live Vaccines Market Forecast (2019-2027)
Figure Brazil Live Vaccines Market Forecast (2019-2027)
Figure Argentina Live Vaccines Market Forecast (2019-2027)
Figure Columbia Live Vaccines Market Forecast (2019-2027)
Figure Rest of South America Live Vaccines Market Forecast (2019-2027)
Figure Middle East and Africa Live Vaccines Market Forecast (2019-2027)
Figure Saudi Arabia Live Vaccines Market Forecast (2019-2027)
Figure United Arab Emirates Live Vaccines Market Forecast (2019-2027)
Figure Egypt Live Vaccines Market Forecast (2019-2027)
Figure Nigeria Live Vaccines Market Forecast (2019-2027)
Figure South Africa Live Vaccines Market Forecast (2019-2027)
Figure Turkey Live Vaccines Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Live Vaccines Market Forecast (2019-2027)
Figure Global Live Vaccines Forecast by Type (2019-2027)
Figure Global Live Vaccines Market Share Forecast by Type (2019-2027)
Figure Global Live Vaccines Forecast by Type (2019-2027)
Figure Global Live Vaccines Forecast by Application (2019-2027)
Figure Global Live Vaccines Market Share Forecast by Application (2019-2027)
Figure Global Live Vaccines Forecast by Application (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|